- Presentations
- Documents
- Infographics
CCO immune checkpoint_inhibitors_in_cancer_care
Adonis Guancia
•
8 years ago
Oncology Immunotherapy - Nivolumab and other PD-1/PD-L1 Targeted Agents (061213)
Will Roettger
•
10 years ago
PD1 & PD L1 Targeted Agents - Nivolumab Clinical & Commercial Development (110113)
Will Roettger
•
10 years ago
Immuno-Oncology: A Colloquium on the State of the Science for Oncology Clinicians
Institute For Medical Education and Research (IMER)
•
11 years ago
The immune checkpoint landscape in 2015: combination therapy
Paul D. Rennert
•
9 years ago
RATIONAL COMBINATION IMMUNOTHERAPY: The best of ASCO16 clinical data
Paul D. Rennert
•
7 years ago